Bluejay Diagnostics Enrolls 545 Patients In SYMON II Study And Reports Manufacturing Readiness Progress Including Antibody Supply For Over 10M Test Cartridges Into 2026

Bluejay Diagnostics, Inc. -2.56%

Bluejay Diagnostics, Inc.

BJDX

1.90

-2.56%

Bluejay Diagnostics Enrolls 545 Patients In SYMON II Study And Reports Manufacturing Readiness Progress Including Antibody Supply For Over 10M Test Cartridges Into 2026
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via